Abcellera Biologics Inc (ABCL) — Financial Flexibility Index
Abcellera Biologics Inc (ABCL) has a Financial Flexibility Index of -0.08x as of March 2026. Free cash flow of $-29.69 Million (operating CF $-33.52 Million minus capex $3.83 Million) represents 0% of total liabilities ($369.03 Million). Check strategic asset allocation of Abcellera Biologics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Abcellera Biologics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Abcellera Biologics Inc across 8 annual periods. See ABCL current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Abcellera Biologics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Abcellera Biologics Inc. For the full company profile including market capitalisation, see Abcellera Biologics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-88.52 Million | $-131.29 Million | $390.05 Million | ▼ -129.1% |
| 2024 | -0.10x | $-30.16 Million | $-108.56 Million | $304.47 Million | ▼ -198.9% |
| 2023 | 0.10x | $33.63 Million | $-43.88 Million | $335.78 Million | ▼ -91.2% |
| 2022 | 1.14x | $350.02 Million | $277.36 Million | $307.63 Million | ▲ +9.9% |
| 2021 | 1.03x | $303.04 Million | $244.58 Million | $292.84 Million | ▲ +384.8% |
| 2020 | 0.21x | $37.36 Million | $22.69 Million | $175.03 Million | ▼ -57.8% |
| 2019 | 0.51x | $6.69 Million | $2.69 Million | $13.24 Million | ▼ -43.7% |
| 2018 | 0.90x | $8.87 Million | $3.56 Million | $9.88 Million | — |